Financial reports
10-K/A
2023 FY
Annual report (amended)
14 Mar 24
10-K
2023 FY
Annual report
13 Mar 24
10-Q
2023 Q3
Quarterly report
15 Nov 23
NT 10-Q
Notice of late quarterly filing
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
Current reports
8-K
Submission of Matters to a Vote of Security Holders
19 Apr 24
8-K
Entry into a Material Definitive Agreement
17 Apr 24
8-K
Entry into a Material Definitive Agreement
26 Mar 24
8-K
Amendments to Articles of Incorporation or Bylaws
14 Mar 24
8-K
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
14 Mar 24
8-K/A
Entry into a Material Definitive Agreement
29 Feb 24
8-K/A
Entry into a Material Definitive Agreement
29 Feb 24
8-K
ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share
8 Feb 24
8-K/A
Report of Independent Registered Public Accounting Firm
26 Jan 24
8-K/A
Entry into a Material Definitive Agreement
17 Jan 24
Registration and prospectus
424B4
Prospectus supplement with pricing info
5 Apr 24
S-1/A
IPO registration (amended)
22 Mar 24
S-1/A
IPO registration (amended)
16 Feb 24
S-1/A
IPO registration (amended)
9 Feb 24
S-1
IPO registration
12 Jan 24
424B4
Prospectus supplement with pricing info
17 Nov 23
424B3
Prospectus supplement
17 Nov 23
424B4
Prospectus supplement with pricing info
17 Nov 23
424B4
Prospectus supplement with pricing info
17 Aug 23
424B3
Prospectus supplement
17 Aug 23
Proxies
DEFA14A
Additional proxy soliciting materials
25 Mar 24
DEFA14A
Additional proxy soliciting materials
14 Mar 24
DEF 14A
Definitive proxy
29 Dec 23
PRE 14A
Preliminary proxy
15 Dec 23
DEF 14A
Definitive proxy
21 Jun 23
PRE 14A
Preliminary proxy
31 May 23
DEF 14A
Definitive proxy
14 Apr 23
PRE 14A
Preliminary proxy
3 Apr 23
DEF 14A
Definitive proxy
27 Apr 22
DEF 14A
Definitive proxy
20 Jan 11
Other
EFFECT
Notice of effectiveness
2 Apr 24
EFFECT
Notice of effectiveness
9 Jun 23
CORRESP
Correspondence with SEC
7 Jun 23
CORRESP
Correspondence with SEC
1 Jun 23
UPLOAD
Letter from SEC
11 May 23
CORRESP
Correspondence with SEC
10 May 23
UPLOAD
Letter from SEC
3 May 23
EFFECT
Notice of effectiveness
2 May 23
EFFECT
Notice of effectiveness
2 May 23
EFFECT
Notice of effectiveness
24 Jun 22
Ownership
SC 13G/A
Lind Global Fund II LP
13 Feb 24
SC 13G
Lind Global Fund II LP
7 Aug 23
3
Shuling Jiang
12 Jul 22
SC 13D
Jiang Shuling
12 Jul 22
3
Chihliang An
31 Mar 22
3
Norimi Sakamoto
10 Dec 21
3
Yoshinobu Odaira
10 Dec 21
3
Tsung Shann Jiang
15 Nov 21
3
Shin-Yu Miao
15 Nov 21
3
Shih-Chen Tseng
15 Nov 21